|
Quotes & Info
|
| AEMD.OB > SEC Filings for AEMD.OB > Form 8-K on 4-Aug-2008 | All Recent SEC Filings |
4-Aug-2008
Other Events, Financial Statements and Exhibits
On July 31, 2008, Richard H. Tulis, acquired 468,750 shares of common stock at the closing market price of $0.32 per share in exchange for forgiveness of debt. Dr. Tullis is Vice President, Chief Science Officer and is a Director of the Company. The debt was incurred in prior years and related to salary and expenses. The conversion was memorialized in a letter agreement with the Company and approved by the Board of Directors, dated July 31, 2008. These securities were issued in reliance upon an exemption from registration pursuant to Section 4(2) of the Securities Act of 1933.
(d) EXHIBITS
ITEM NO. DESCRIPTION
10.1 Letter agreement between Aethlon Medical, Inc. and Richard H.
Tullis
|
|